Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ISRCTN |
Last refreshed on:
|
13 January 2015 |
Main ID: |
ISRCTN47368803 |
Date of registration:
|
11/09/2003 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
IBS-C Study A2306
|
Scientific title:
|
|
Date of first enrolment:
|
01/04/2002 |
Target sample size:
|
0 |
Recruitment status: |
Completed |
URL:
|
http://isrctn.com/ISRCTN47368803 |
Study type:
|
Interventional |
Study design:
|
Randomised controlled trial (Not Specified)
|
Phase:
|
|
|
Countries of recruitment
|
United States of America
| | | | | | | |
Contacts
|
Name:
|
|
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
|
Name:
|
Marisa
Carmen |
Address:
|
Novartis Pharmaceuticals
One Health Plaza
07936
East Hanover
United States of America |
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: Females, 18 to 65 years, with IBS-C (Irritable Bowel Syndrome with constipation)
Exclusion criteria: Not provided at time of registration.
Age minimum:
Age maximum:
Gender:
Female
|
Health Condition(s) or Problem(s) studied
|
Irritable bowel syndrome (IBS) with constipation Digestive System Irritable bowel syndrome (IBS) with constipation
|
Intervention(s)
|
Not provided at time of registration.
|
Primary Outcome(s)
|
Not provided at time of registration.
|
Secondary Outcome(s)
|
Not provided at time of registration.
|
Secondary ID(s)
|
CHTF919A2306
|
Source(s) of Monetary Support
|
Sponsored by Novartis Pharmaceuticals Corporation (http://click.atdmt.com/GTO/go/thbmbnov00700895gto/direct/01/)
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|